Legis Daily

Affordable Drug Manufacturing Act of 2020

USA116th CongressS-3162| Senate 
| Updated: 1/8/2020
Elizabeth Warren

Elizabeth Warren

Democratic Senator

Massachusetts

Health, Education, Labor, and Pensions Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Affordable Drug Manufacturing Act of 2020 This bill establishes the Office of Drug Manufacturing within the Department of Health and Human Services to lower prices for, increase access to, and address shortages of prescription drugs (e.g., insulin, naloxone, and antibiotics), including by manufacturing prescription drugs and selling them at a fair price.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 20, 2019

Latest Companion Bill Action

HR 116-5501
Referred to the Subcommittee on Health.
Jan 8, 2020
Introduced in Senate
Jan 8, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • December 20, 2019

    Latest Companion Bill Action

    HR 116-5501
    Referred to the Subcommittee on Health.


  • January 8, 2020
    Introduced in Senate


  • January 8, 2020
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Health

Related Bills

  • HR 116-5501: Affordable Drug Manufacturing Act of 2019
Competition and antitrustCongressional oversightDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureFederal officialsGovernment employee pay, benefits, personnel managementHealth care costs and insuranceHealth care coverage and accessHealth care qualityHealth programs administration and fundingInflation and pricesLicensing and registrationsManufacturingPrescription drugsPublic contracts and procurementPublic participation and lobbying

Affordable Drug Manufacturing Act of 2020

USA116th CongressS-3162| Senate 
| Updated: 1/8/2020
Affordable Drug Manufacturing Act of 2020 This bill establishes the Office of Drug Manufacturing within the Department of Health and Human Services to lower prices for, increase access to, and address shortages of prescription drugs (e.g., insulin, naloxone, and antibiotics), including by manufacturing prescription drugs and selling them at a fair price.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 20, 2019

Latest Companion Bill Action

HR 116-5501
Referred to the Subcommittee on Health.
Jan 8, 2020
Introduced in Senate
Jan 8, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • December 20, 2019

    Latest Companion Bill Action

    HR 116-5501
    Referred to the Subcommittee on Health.


  • January 8, 2020
    Introduced in Senate


  • January 8, 2020
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Elizabeth Warren

Elizabeth Warren

Democratic Senator

Massachusetts

Health, Education, Labor, and Pensions Committee

Health

Related Bills

  • HR 116-5501: Affordable Drug Manufacturing Act of 2019
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Competition and antitrustCongressional oversightDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureFederal officialsGovernment employee pay, benefits, personnel managementHealth care costs and insuranceHealth care coverage and accessHealth care qualityHealth programs administration and fundingInflation and pricesLicensing and registrationsManufacturingPrescription drugsPublic contracts and procurementPublic participation and lobbying